Citigroup Inc Nutri Band Inc. Call Options Transaction History
Citigroup Inc
- $190 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NTRB
# of Institutions
19Shares Held
341KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA199KShares$1.12 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA63.6KShares$357,1510.0% of portfolio
-
State Street Corp Boston, MA17.3KShares$97,0340.0% of portfolio
-
Haven Private, LLC Orlando, FL11.5KShares$64,7480.04% of portfolio
-
Northern Trust Corp Chicago, IL11.5KShares$64,5280.0% of portfolio
About NutriBand Inc.
- Ticker NTRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,803,260
- Market Cap $43.9M
- Description
- Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid the...